Literature DB >> 8105046

Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.

B Delahunt1, P B Bethwaite, J N Nacey, J L Ribas.   

Abstract

Proliferating cell nuclear antigen (PCNA) expression in renal cell carcinoma (RCC) was determined by immunohistochemical staining using the PC10 clone. PCNA indices ranged from 2.4 to 53.1 per cent with mean indices of 12.6, 19.0, and 31.6 per cent for grades 1 to 3 RCC and 31.9 per cent for sarcomatoid RCC. There was a significant difference between the indices of grades 1 and 3 and grades 2 and 3 tumours and between grades 1 and 2 RCC and sarcomatoid RCC. AgNOR scores and mitotic indices were determined for each tumour and comparison of PCNA indices with mean AgNOR scores and mitotic indices showed only a weak correlation (PCNA/AgNOR r = 0.406, PCNA/mitotic index r = 0.315). Tumours were divided according to PCNA index (< or = 18 per cent and > 18 per cent) and there was a significant difference in survival between the two groups, for all cases, and for each of the Robson stages. Multivariate analysis using Cox's proportional hazard model showed PCNA index, tumour stage, and mean AgNOR score to be independent predictors of survival, while tumour grade and mitotic index were found to be dependent variables.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105046     DOI: 10.1002/path.1711700411

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  7 in total

1.  Bone marrow tissue and proliferation markers: results and general problems.

Authors:  J Thiele; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 2.  Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies.

Authors:  Brian Shuch; Gennady Bratslavsky; W Marston Linehan; Ramaprasad Srinivasan
Journal:  Oncologist       Date:  2012-01-10

3.  Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.

Authors:  R Houston Thompson; Michael D Gillett; John C Cheville; Christine M Lohse; Haidong Dong; W Scott Webster; Kent G Krejci; John R Lobo; Shomik Sengupta; Lieping Chen; Horst Zincke; Michael L Blute; Scott E Strome; Bradley C Leibovich; Eugene D Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

4.  Proliferation kinetics of streptozotocin-induced renal tumours in mice.

Authors:  B Delahunt; P R Cartwright; A Thornton; P J Dady
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 5.  The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours.

Authors:  G Kovacs
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

6.  VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value.

Authors:  Ayhan Dirim; Asuman Nihan Haberal; Mehmet Resit Goren; Mehmet Ilteris Tekin; Levent Peskircioglu; Beyhan Demirhan; Hakan Ozkardes
Journal:  Int Urol Nephrol       Date:  2008-03-07       Impact factor: 2.370

7.  Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas.

Authors:  X Xie; O P Clausen; P De Angelis; M Boysen
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.